Cargando…
Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
Advanced prostate cancers frequently develop resistance to androgen-deprivation therapy with serious implications for patient survival. Considering their importance in this type of neoplasia, epigenetic modifications have drawn attention as alternative treatment strategies. The aim of this study was...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391120/ https://www.ncbi.nlm.nih.gov/pubmed/34440180 http://dx.doi.org/10.3390/biomedicines9080976 |